subject: The Future Of High Potency Active Pharmaceutical Ingredients (hpapis) [print this page] The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity
Summary
The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity. The study, which is an offering from the companys Chemicals Research Group, provides in-depth analysis of the global HPAPIs market with revenue forecasts up to 2015. Revenue forecasts, which include historical statistics of the market, are provided for the major regions Europe, North America and Asia Pacific. The factors that drive and restrain the growth of the HPAPIs market are also analyzed in the report. In addition, the research provides market share analysis of the leading HPAPIs producers for major regions. The market for HPAPIs is also analyzed based on the product types and therapeutic applications at a global level. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.
Scope
- HPAPIs market revenues data from 2005 to 2009 and forecast for six years to 2015.
- HPAPIs in key regions Europe, North America and Asia Pacific.
- Coverage of the product types and therapeutic applications of the global HPAPIs market.
- Drivers such as increasing demand due to the growth in better targeted drugs and restraints such as the economic recession for the global market as well as for the regional markets.
- Information on the competitive landscape with the revenue shares of the leading companies in the major regions of the world such as Sigma Aldrich, Bristol Myers Squibb, Sanofi Aventis, Carbogen Amcis and Novasep.
